ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Clinical criteria, recommended screening, and inherited alterations of familial gastric cancer syndromes

Clinical criteria, recommended screening, and inherited alterations of familial gastric cancer syndromes
  Clinical criteria Genetic screening Alterations described
Hereditary diffuse gastric cancer

Two or more cases of gastric cancer, one confirmed case of diffuse gastric cancer in someone younger than 50 years

Three or more confirmed diffuse gastric cancer cases in first-degree or second-degree relatives, independent of age of onset

Diffuse gastric cancer before age 40 years without a family history

Sequencing of CDH1 coding sequences

Multiplex ligation-dependent probe amplification (large CDH1 rearrangements)
Mutations throughout the CDH1 gene and deletions mainly implicating flanking untranslated regions
Personal or family history of diffuse gastric cancer and lobular breast cancer, one of which must be diagnosed before age 50 years Sequencing of CTNNA1 coding sequences One germline truncating mutation in CTNNA1
Gastric adenocarcinoma and proximal polyposis of the stomach

Gastric polyps restricted to the body and fundus with no evidence of colorectal or duodenal polyposis

More than 100 polyps carpeting the proximal stomach in the index case or more than 30 polyps in a first-degree relative of another case

Mainly fundic gastric polyps, some with regions of dysplasia (or a family member with either dysplastic fundic gastric polyps or gastric adenocarcinoma)

Autosomal dominant pattern of inheritance

Exclusions include other heritable gastric polyposis syndromes and use of proton pump inhibitors*
No screening available No inherited mutations so far
Familial intestinal gastric cancer

Two or more cases of gastric cancer in first-degree or second-degree relatives, with at least one confirmed case of intestinal histology in someone younger than 50 years

Three or more confirmed cases of intestinal gastric cancer in first-degree or second-degree relatives, independent of age
No screening available No inherited mutations so far
* Proton pump inhibitors can induce a proximal polyposis of the stomach that may mimic a gastric adenocarcinoma. Patients taking these drugs should undergo a repeat endoscopy off-therapy to confirm the diagnosis of gastric adenocarcinoma versus proximal polyposis of the stomach.
Reproduced from: Olivieria C, Pinhiero H, Figueiredo J, et al. Familial gastric cancer: genetic susceptibility, pathology, and implications for management. Lancet Oncol 2015; 16:e60. Table used with the permission of Elsevier Inc. All rights reserved.
Graphic 101357 Version 4.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟